Project Grant HT94252510280
Award Date
5/1/25
Completion Date
4/30/29
Dollars Obligated
$750K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Houston, TX 77204, USA
Similar Awards
This federal Project Grant award, valued at $1,555,000.00, was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports the University of Wisconsin System's research initiative to develop population modeling to optimize equitable ovarian cancer outcomes. The project aims to transform healthcare for military service members and the broader public by advancing innovative research on disease prevention, diagnosis, and...
The University of Houston received a $299,787 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund a research project from May 1, 2023 to April 30, 2025 to evaluate the diagnostic utility of antibodies to histone post-translational modifications in pediatric lupus patients. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with...
The federal Project Grant award, with ID HT94252410992, was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award, totaling $2,710,479.00, will fund a research initiative led by the University of Texas M.D. Anderson Cancer Center to advance the understanding of metastatic breast cancer through the development of a comprehensive research platform. The award's performance period is from August 15, 2024 to...
The federal Project Grant award, valued at $613,125.00 and effective from February 1, 2025 to January 31, 2028, was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports research conducted by the University of Texas MD Anderson Cancer Center to develop EGFRXHER3 bispecific CAR-T cells for targeting EGFR tyrosine kinase inhibitor drug-tolerant persister cells. This advanced cancer research initiative...
The federal Project Grant award, valued at $718,858.00 and funded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research to discover non-canonical antigens in triple-negative breast cancer for the development of novel T cell therapies. The award recipient is The University of Texas MD Anderson Cancer Center, a premier academic cancer research and treatment institution. The research aims to transform healthcare for military...
This Project Grant award for $699,750 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to the University of Washington aims to support the discovery and characterization of tissue-specific regulatory mutations that predispose to ovarian cancer. The award will fund research activities over a 3-year period from April 2024 to March 2027. As a leading research university, the University of Washington has extensive experience managing federal grants and...
The University of Houston System, a Hispanic Serving Institution, was awarded a $604,500 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Targeting PRMT5 in MTAP-Loss Melanoma." The three-year project, which runs from September 30, 2023 to September 29, 2026, aims to investigate medical solutions for the battlefield through advanced biomedical research to transform health care for service...
This federal Project Grant award in the amount of $1,439,093.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of New Mexico Health Sciences Center (UNM HSC). The grant will support advancing clinical research on ovarian cancer over a performance period from June 1, 2024 to May 31, 2028. As part of this award, UNM HSC will leverage its expertise in cancer research, genomics, and clinical trials to conduct...
The federal Project Grant award of $457,185.00, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a research project led by Clemson University to characterize fallopian tube-derived extracellular vesicles for the discovery of ovarian cancer biomarkers. The 2-year project, running from July 1, 2024 to June 30, 2026, will leverage Clemson University's expertise in areas like cancer research, biomedical engineering, and...
The University of Houston System, a Hispanic-Serving Institution, was awarded a $1,101,840 federal Project Grant under the Department of Defense's Military Medical Research and Development program (CFDA 12.420). The grant, awarded on January 1, 2024, supports a research project titled "INVESTIGATING NEBIVOLOL IN TRIPLE-NEGATIVE BREAST CANCER" to be completed by December 31, 2026. The project aims to develop new treatments and advance scientific understanding of military health...